08 April 2019 2 Min Read
EDITOR’S NOTE: Election jitters adding to blue-chip woes
The recent ‘bad let-downs’ at respected blue-chip companies such as Aspen Pharmacare and Tongaat Hulett were just the kind of sentiment-souring episodes the JSE did not need
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In